Correspondence

Journal of Dermatological Treatment

Volumn 12, Issue 1, 2001, Pages 59-60

  Lee, M W ^a   Lee, W S ^a   Choi, J H ^a   Sung, K J ^a   Moon, K C ^a   Koh, J K ^a  

^a University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CEFAZOLIN; CORTICOSTEROID; DAPSONE; PREDNISOLONE; TETRACYCLINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; LETTER; PEMPHIGOID; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT PLANNING; BULLOUS PEMPHIGOID; DRUG COMBINATION; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SEPSIS;

DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; PEMPHIGOID, BULLOUS; PLASMAPHERESIS; SEPSIS;

EID: 0035034033     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/095466301750163617     Document Type: Letter

References (6)

1. Bullous pemphigoid. The latest in diagnosis, prognosis, and therapy
2. Plasma exchange in bullous pemphigoid
3. Plasma exchange in corticosteroid-resistant pemphigus
4. Plasmapheresis treatment for bullous pemphigoid induces marked reduction of the serum IL-6 level rather than titre of circulating autoantibodies
5. Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid
6. Long-term plasma exchange therapy in bullous pemphigoid